We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (21)
- Safety monitoring and information (13)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
Collection content
113 result(s) found, displaying 71 to 80
-
GuidanceGuidance on the regulatory requirements for therapeutic goods that contain, or are produced from, human blood or plasma.
-
PageInformation about the shortage and the Serious Scarcity Substitution Instrument
-
PageInformation about the shortage and the Serious Scarcity Substitution Instrument
-
FormsUpdated form used to notify us of proprietary ingredient mixtures for use in therapeutic goods.
-
User guideInformation on how to compile a literature based submission (including mixed applications).
-
Medicine shortage alertsPharmacists can dispense 200 mg tablets during the shortage.
-
-
User guideHow to search TGA business services for approved ingredients and accepted TGA terminology.
-
User guideThis document replaces AU eCTD specification - Module 1 and regional information Version 3.0 and contains updated information.
-
FormsSponsors can use this form to apply for an additional trade name for a registered prescription medicine, under section 23 of the Therapeutic Goods Act 1989.